AbbVie Bid for Biotech Could Expand with Experimental Drug
AbbVie is exploring a cash purchase of about $10.9 billion for a biotech developing an experimental eczema drug, a mo...
Value investing basics can set you on a path to success. Learn how to identify undervalued stocks and maximize returns.
20,091 articlesAbbVie is exploring a cash purchase of about $10.9 billion for a biotech developing an experimental eczema drug, a mo...
Alphabet is branching far beyond search, funding a sweeping AI infrastructure push. This article unpacks why wall str...
Clive Davis, the legendary talent scout who built Arista and launched icons like Whitney Houston, has died at age 94,...
Amazon delivered strong AWS growth and solid Q1 results, but a large capex plan keeps investors wary. Still, a broad ...
AARP launches its largest Community Challenge round yet, awarding $8.3 million to fund 750 projects that upgrade hous...
When a top executive sells a large block of stock, investors often wonder about the meaning behind the move. This gui...
Retail buyers are chasing physical card collectibles tied to crypto platforms, signaling a shift from traditional Tre...
A Seattle-based agent is named a 2026 NAR Fair Housing Champion for spearheading a decade-long push to standardize ho...
Paris Saint-Germain is testing a global lifestyle brand built on the idea that a football club can be more than its s...
Micron Technology faces a pivotal moment as AI memory demand accelerates. Analysts weigh a potential multi-year upcyc...
A Florida grocery worker allegedly exploited lottery access to scan scratch-offs, netting tens of thousands in winnin...
Celebrity pet buys spark debate about money, ethics, and budgeting. This guide translates that moment into practical ...